Jane Street Group, LLC Biogen Inc. Put Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $12.3 Million - $15.5 Million	65,300 New	65,300 $12.7 Million
Q1 2022 May 17, 2022	SELL	$193.77 - $244.14 $3.7 Million - $4.66 Million	-19,100 Reduced 5.68%	317,100 $66.8 Million
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $492,624 - $633,094	2,200 Added 0.66%	336,200 $80.7 Million
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $16 Million - $20.8 Million	-56,400 Reduced 14.45%	334,000 $94.5 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $42.8 Million - $68.5 Million	165,200 Added 73.36%	390,400 $135 Million
Q1 2021 May 18, 2021	SELL	$242.95 - $284.63 $62.8 Million - $73.6 Million	-258,500 Reduced 53.44%	225,200 $63 Million
Q4 2020 Feb 17, 2021	BUY	$236.26 - $355.63 $37.6 Million - $56.6 Million	159,200 Added 49.06%	483,700 $118 Million
Q3 2020 Nov 17, 2020	BUY	$264.77 - $305.71 $16.6 Million - $19.1 Million	62,600 Added 23.9%	324,500 $92.1 Million
Q2 2020 Aug 17, 2020	BUY	$258.66 - $342.55 $24.8 Million - $32.9 Million	95,900 Added 57.77%	261,900 $70.1 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $9.71 Million - $12.3 Million	36,100 Added 27.79%	166,000 $52.5 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $7.22 Million - $9.97 Million	-32,800 Reduced 20.16%	129,900 $38.5 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $20.9 Million - $23.5 Million	96,200 Added 144.66%	162,700 $37.9 Million
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $27 Million - $29.7 Million	-122,900 Reduced 64.89%	66,500 $15.6 Million
Q1 2019 May 16, 2019	BUY	$216.71 - $338.96 $38.1 Million - $59.5 Million	175,600 Added 1272.46%	189,400 $44.8 Million
Q4 2018 Feb 15, 2019	SELL	$278.5 - $352.75 $1.73 Million - $2.19 Million	-6,200 Reduced 31.0%	13,800 $4.15 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $5.75 Million - $7.52 Million	-19,600 Reduced 49.49%	20,000 $7.07 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $3.99 Million - $4.76 Million	15,500 Added 64.32%	39,600 $11.5 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $15.5 Million - $21.9 Million	-59,500 Reduced 71.17%	24,100 $6.6 Million
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $14.7 Million - $16.5 Million	47,800 Added 133.52%	83,600 $26.6 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $10.1 Million - $11.8 Million	35,800	35,800 $11.2 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account